ACLY expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.117800E-01
Normal-vs-Stage2
7.512000E-01
Normal-vs-Stage3
1.669560E-01
Normal-vs-Stage4
1.104440E-01
Stage1-vs-Stage2
1.039970E-02
Stage1-vs-Stage3
4.950000E-02
Stage1-vs-Stage4
5.604600E-01
Stage2-vs-Stage3
1.197780E-01
Stage2-vs-Stage4
2.319800E-01
Stage3-vs-Stage4
1.358200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.596400E-01
Normal-vs-AfricanAmerican
4.478000E-01
Normal-vs-Asian
5.762600E-01
Caucasian-vs-AfricanAmerican
7.916400E-01
Caucasian-vs-Asian
2.295900E-02
AfricanAmerican-vs-Asian
9.148400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.893800E-01
Normal-vs-Female
6.124400E-01
Male-vs-Female
8.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.856600E-01
Normal-vs-Age(41-60Yrs)
4.475000E-01
Normal-vs-Age(61-80Yrs)
7.926400E-01
Normal-vs-Age(81-100Yrs)
9.991800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.531600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.409790E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.402600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.156300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.201600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.605800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.844400E-01
Normal-vs-Daily Drinker
6.884600E-01
Normal-vs-Weekly Drinker
8.917200E-01
Normal-vs-Occasional Drinker
4.071200E-01
Normal-vs-Social Drinker
4.464800E-01
Non Drinker-vs-Daily Drinker
2.707400E-01
Non Drinker-vs-Weekly Drinker
9.579200E-01
Non Drinker-vs-Occasional Drinker
8.706000E-02
Non Drinker-vs-Social Drinker
1.648600E-01
Daily Drinker-vs-Weekly Drinker
3.459000E-01
Daily Drinker-vs-Occasional Drinker
2.535600E-02
Daily Drinker-vs-Social Drinker
4.802100E-02
Weekly Drinker-vs-Occasional Drinker
8.984200E-02
Weekly Drinker-vs-Social Drinker
1.692040E-01
Occasional Drinker-vs-Social Drinker
7.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.435000E-01
Normal-vs-Grade 2
6.135700E-02
Normal-vs-Grade 3
3.162400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.362210E-01
Grade 1-vs-Grade 3
1.245790E-01
Grade 1-vs-Grade 4
2.435000E-01
Grade 2-vs-Grade 3
8.716200E-01
Grade 2-vs-Grade 4
6.135700E-02
Grade 3-vs-Grade 4
3.162400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.420600E-01
Normal-vs-NonDiabetic
6.840000E-01
Diabetic-vs-NonDiabetic
5.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.022800E-01
Normal-vs-NoPancreatitis
6.753600E-01
Pancreatitis-vs-NoPancreatitis
1.444120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.169200E-01
Normal-vs-N1
7.175600E-01
N0-vs-N1
2.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.298000E-01
Normal-vs-TP53-NonMutant
3.579800E-02
TP53-Mutant-vs-TP53-NonMutant
4.204300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
